CAPLIPOINTNSECAPLIN POINT LAB LTD.MediumNeutral
Announced Wed, 12 Aug · 15:06 IST

Caplin Point Q1 FY27: Revenue up 20.7%, PAT at Rs 179 Cr; Rs 4 final dividend

Order Pipeline DisclosedAnalyst Day Multiyear TargetsInvestor Communications View source PDFExplain this filing

CAPLIPOINT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-4.8%1-day move
₹2630.00
prior close
₹2483.40
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.3-0.9-4.8-5.4-4.0-3.8-2.1-2.3
Up moveDown movePending
AI summary

Caplin Point Q1 FY27 consolidated revenue rose 20.7% YoY to Rs 644 Cr, with PAT up 18.8% to Rs 179 Cr. US revenue grew 26% to Rs 137 Cr. EBITDA margin improved to 38.4% from 37.7%. Board recommended final dividend of Rs 4/share (200%), taking total FY26 dividend to Rs 8/share (400%). Re-appointed MD Sridhar Ganesan for 2 years and appointed D Muralidharan as Whole-Time Director. Capex of Rs 1,000+ Cr planned over 2-3 years, funded through internal accruals. Free cash reserves stand at Rs 1,502 Cr, liquid assets at Rs 2,875 Cr.

Likely market impact

Strong Q1 with double-digit growth, healthy dividend payout, and net cash-positive capex plan likely to be viewed positively by investors.